Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)

Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, Axel Benner, Marion Moos, Anja Seckinger, Stephanie Pschowski-Zuck, Désirée Kirn, Kai Neben, Claus R. Bartram, Anthony D. Ho, Hartmut Goldschmidt, Dirk Hose, Anna Jauch, Stefan O. Schonland

Blood (2011) 117 (14): 3809–3815.

https://doi.org/10.1182/blood-2010-02-268987

Published: 2011

Journal Articles

Hyperdiploidy Is Rare in Patients with AL Amyloidosis – Identification of Major Cytogenetic Groups in Early Monoclonal Plasma Cell Disorders.

Tilmann Bochtler, Ute Hegenbart, MD, Christiane Heiss, Axel Benner, Stephanie Pschowski-Zuck, Désirée Kirn, Kai Neben, Marion Moos, D. Hose, Claus R Bartram, MD, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Anna Jauch, Stefan Schonland

Blood (2009) 114 (22): 2823.

https://doi.org/10.1182/blood.V114.22.2823.2823

Published: 2009

Journal Articles

Osteoclast Gene Expression Profiling in Multiple Myeloma

Jerome Moreaux, Dirk Hose, Thierry Rème, Philippe Moine, Karène Mahtouk, Marion Moos, Guilhem Requirand, John De Vos, PhD, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2008) 112 (11): 2735.

https://doi.org/10.1182/blood.V112.11.2735.2735

Published: 2008

Journal Articles

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

Tilmann Bochtler, Ute Hegenbart, Friedrich W. Cremer, Christiane Heiss, Axel Benner, Dirk Hose, Marion Moos, Jelena Bila, Claus R. Bartram, Anthony D. Ho, Hartmut Goldschmidt, Anna Jauch, Stefan O. Schonland

Blood (2008) 111 (9): 4700–4705.

https://doi.org/10.1182/blood-2007-11-122101

Published: 2008

Journal Articles

Ribosomal Proteins Are Overexpressed in Hyperdiploid Multiple Myeloma.

Niels Weinhold, John DeVos, PhD, Dirk Hose, Jean-Francois Rossi, MD, Benner Axel, Karène Mahtouk, PhD, Marc S. Raab, MD, Thierry X. Rème, PhD, Anna Jauch, PhD, Jerome Moreaux, PhD, Veronique Pantesco, Hartmut Goldschmidt, MD, Eric Jourdan, MD, Friedrich W. Cremer, MD, Bernard Klein, MD, PhD, Marion Moos, PhD

Blood (2007) 110 (11): 2495.

https://doi.org/10.1182/blood.V110.11.2495.2495

Published: 2007

Journal Articles

Evaluation of the Cytogenetic Aberration Pattern in AL Amyloidosis Compared to Monoclonal Gammopathies Not Requiring Treatment: Translocation t(11;14) Is More Frequent in AL Amyloidosis.

Tilmann Bochtler, MD, Stefan O. Schonland, MD, Anna Jauch, PhD, Christiane Heiss, Axel Benner, PhD, Friedrich W. Cremer, MD, Dirk Hose, Marion Moos, PhD, Claus R. Bartram, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Ute Hegenbart, MD

Blood (2007) 110 (11): 2500.

https://doi.org/10.1182/blood.V110.11.2500.2500

Published: 2007

Journal Articles

CD200 is a new prognostic factor in multiple myeloma

Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Eric Legouffe, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Möhler, John De Vos, Jean Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (13): 4194–4197.

https://doi.org/10.1182/blood-2006-06-029355

Published: 2006

Includes: Supplemental data

Journal Articles

CD200 Is a New Prognostic Factor in Multiple Myeloma.

Jerome Moreaux, Dirk Hose, Thierry X. Reme, Eric Jourdan, Michael Hundemer, Legouffe Eric, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Mölher, John DeVos, Jean-Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (11): 4997.

https://doi.org/10.1182/blood.V108.11.4997.4997

Published: 2006

Journal Articles

Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS).

Blood (2005) 106 (11): 507.

https://doi.org/10.1182/blood.V106.11.507.507

Published: 2005

Journal Articles

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Jerome Moreaux, Friedrich W. Cremer, Thierry Reme, Karene Mahtouk, Veronique Pantesco, John de Vos, Marion Moos, Nicolas Robert, Hartmut Goldschmidt, Jean-François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 3400.

https://doi.org/10.1182/blood.V106.11.3400.3400

Published: 2005

Journal Articles

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Karène Mahtouk, Friedrich W. Cremer, Thierry Rème, Michel Jourdan, Marion Baudard, Jérome Moreaux, Guilhem Requirand, Geneviève Fiol, John De Vos, Marion Moos, Philippe Quittet, Hartmut Goldschmidt, Jean-Francois Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 626.

https://doi.org/10.1182/blood.V106.11.626.626

Published: 2005

Journal Articles

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Jérôme Moreaux, Friedrich W. Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Philine Kaukel, Veronique Pantesco, John De Vos, Eric Jourdan, Anna Jauch, Eric Legouffe, Marion Moos, Genevieve Fiol, Hartmut Goldschmidt, Jean François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (3): 1021–1030.

https://doi.org/10.1182/blood-2004-11-4512

Published: 2005

Includes: Supplemental data

Journal Articles

Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.

Friedrich W. Cremer, John De Vos, Dirk Hose, Jean François Rossi, Carina Ittrich, Thierry Rème, Axel Benner, Eric Jourdan, Marc S. Raab, Jelena Bila, Ann-Cathrin Theil, Sunitha Jonnakuty, Coral del Val, Marion Moos, Hartmut Goldschmidt, Bernard Klein, Anna Jauch

Blood (2004) 104 (11): 1421.

https://doi.org/10.1182/blood.V104.11.1421.1421

Published: 2004

Journal Articles

A New Molecular Classification of Multiple Myeloma Using Gene Expression Profiling and Fluorescence In Situ Hybridisation as Predictor for Event Free Survival.

Dirk Hose, Jean-Francois Rossi, Carina Ittrich, John deVos, Axel Benner, Thierry Reme, Jelena Bila, Veronique Grau, Marc Raab, Philine Kaukel, Eric Jourdan, Marion Moos, Ann-Cathrin Theil, Anna Jauch, Hartmut Goldschmidt, Bernard Klein, Friedrich W. Cremer

Blood (2004) 104 (11): 73.

https://doi.org/10.1182/blood.V104.11.73.73

Published: 2004

Journal Articles

CD56 as Prognostic Factor in Patients with Multiple Myeloma Treated by High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Michael Hundemer, MD, Ulrike Klein, MD, Dirk Hose, MD, Friedrich Cremer, MD, Marc Raab, MD, Marion Moos, PhD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD

Blood (2004) 104 (11): 947.

https://doi.org/10.1182/blood.V104.11.947.947

Published: 2004

Journal Articles

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

Karène Mahtouk, Dirk Hose, Thierry Reme, John De Vos, Michel Jourdan, Jérome Moreaux, Geneviève Fiol, Marc Raab, Eric Jourdan, Marion Moos, Hartmut Goldschmidt, Jean-François Rossi, Friedrich W. Cremer, Bernard Klein

Blood (2004) 104 (11): 4306.

https://doi.org/10.1182/blood.V104.11.4306.4306

Published: 2004

Journal Articles

Clonotypic B cells in the peripheral blood of patients with multiple myeloma

Friedrich W. Cremer, Hartmut Goldschmidt, Marion Moos

Blood (2001) 97 (9): 2913–2914.

https://doi.org/10.1182/blood.V97.9.2913

Published: 2001

Journal Articles

Lack of t(14; 18) Polymerase Chain Reaction-Positive Cells in Highly Purified CD34 + Cells and Their CD19 Subsets in Patients With Follicular Lymphoma

Maria Teresa Voso, Stefan Hohaus, Marion Moos, Rainer Haas

Blood (1997) 89 (10): 3763–3768.

https://doi.org/10.1182/blood.V89.10.3763

Published: 1997

NARROW

Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)

Hyperdiploidy Is Rare in Patients with AL Amyloidosis – Identification of Major Cytogenetic Groups in Early Monoclonal Plasma Cell Disorders.

Osteoclast Gene Expression Profiling in Multiple Myeloma

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

Ribosomal Proteins Are Overexpressed in Hyperdiploid Multiple Myeloma.

Evaluation of the Cytogenetic Aberration Pattern in AL Amyloidosis Compared to Monoclonal Gammopathies Not Requiring Treatment: Translocation t(11;14) Is More Frequent in AL Amyloidosis.

CD200 is a new prognostic factor in multiple myeloma

CD200 Is a New Prognostic Factor in Multiple Myeloma.

Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS).

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.

A New Molecular Classification of Multiple Myeloma Using Gene Expression Profiling and Fluorescence In Situ Hybridisation as Predictor for Event Free Survival.

CD56 as Prognostic Factor in Patients with Multiple Myeloma Treated by High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

Clonotypic B cells in the peripheral blood of patients with multiple myeloma

Lack of t(14; 18) Polymerase Chain Reaction-Positive Cells in Highly Purified CD34 + Cells and Their CD19 Subsets in Patients With Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only